The verified answer
As of Aug 2026, DEPLOY verifies Vitestro: 1 model, 1 deployment across 1 region, $70.0M raised, 1 active incident. 1 source back the record.
Overview
Dutch medical-robotics company; maker of Aletta, billed as the World's first autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to locate veins and draw blood, with ~94.5% first-stick success and EU MDR approval. Private.
Verified record
- Verified deployments
- 1 deployment on file
- Active incidents
- 1 incident on file
Valuation of record
DEPLOY VERIFIEDPriced roundSeries B post-money
Key facts
Robot
Technology
Performance
Stage
Focus
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Vitestro on the deployment map
View the global map1 verified deployment across 1 region, newest verified Jan 2024. Explore where Vitestro's robots are operating, by place and type.
View the full Vitestro deployment record →
Relationships
Current leadership (2)
- Toon Overbeeke Co-Founder & CEOsecondary-verified
- Brian Joseph Co-Foundersecondary-verified
Founders (2)
- Toon Overbeekecofounder
- Brian Josephcofounder
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Vitestro (1)
- FDA grants De Novo authorization to Vitestro Aletta, first standalone robotic blood draw device2026-08-19 · Regulatory action
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Operator customers (1)
- Vitestro1 deployment
Recent coverage
Vitestro in third-party press
Peers
144 peers across 1 segment. Every Vitestro competitor derived from shared form-factor and application-domain edges.
service(144)
113 companies in this segment · competitive (HHI 831.3520919269878) · leader Bond at 1957%
- 1X Technologiesdirect competitor(inferred)moderate
- A&K Roboticsdirect competitor(inferred)moderate
- Aescapedirect competitor(inferred)moderate
- Allen Control Systemsdirect competitor(inferred)moderate
- Amazondirect competitor(inferred)moderate
- Amity Roboticsdirect competitor(inferred)moderate
Financial state
- Total funding
- $70.0M
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- growth
- Counterparty risk class
- unknown
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Series B2026-07-08
$70M(reported) · $560M post
Timeline
Every recorded move in Vitestro’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
Funding roundSeries B funding round
2026-07-08Series B raising $70000000
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Incident recordedAug 19, 2026
FDA grants De Novo authorization to Vitestro Aletta, first standalone robotic blood draw...
- Record createdJun 24, 2026
Added to the verified registry
- Deployment verifiedVerifiedJan 1, 2024
Aletta at Nieuwegein, Netherlands
Sources (1)
Common questions
What is Vitestro?
What does Vitestro make?
Who competes with Vitestro?
Who is the CEO of Vitestro?
Where is Vitestro headquartered?
How much funding has Vitestro raised?
Where does Vitestro operate robots?
How many robots has Vitestro deployed?
Is Vitestro a top robotics company?
Are there any incidents involving Vitestro?
Is Vitestro safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Vitestro.Peer companies
- Roborock20 models
- Ecovacs Robotics19 models
- SharkNinja14 models
- iRobot9 models
- Mammotion7 models
- DLR Institute of Robotics and Mechatronics6 models
In the press
Recent coverage mentioning Vitestro from third-party publications. Automatically surfaced; not part of the verified registry record.
Vitestro raises 0M to ready blood collection robot for US launch
Vitestro raised 0M in oversubscribed Series B to advance autonomous robotic phlebotomy. EU CE mark gained in 2024, launched in EU healthcare settings March 2025. Preparing US…
Vitestro Unveils Aletta: The World's First Autonomous Robotic Phlebotomy Device
Vitestro unveiled Aletta, the world's first autonomous robotic phlebotomy device (ARPD). Raised 0M Series B for commercial readiness.
Machine-readable surfaces
- Markdown mirror: /companies/vitestro.md
- RSS feed: /companies/vitestro/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/55a81e13-fb85-4bd8-8951-c16d2bd50eff
- Revision history: /companies/vitestro/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Roborock20 models
- Ecovacs Robotics19 models
- SharkNinja14 models
- iRobot9 models
- Mammotion7 models
- DLR Institute of Robotics and Mechatronics6 models
Video
Subscribe to our YouTube channel for free here: https://sc.mp/subscribe-youtube A hospital in eastern China’s Zhejiang province showcased using robots to aid medical workers in drawing blood from patients. After a man
Not all robots walk on two legs. Aletta is a robot that makes drawing blood completely automated. We live in the future
Patients fear needles, nurses struggle with finding veins, and we are all skeptical about robots doing a human’s job. But still, automation seems like the per
Vitestro maakt autonome bloedafname apparaten. In deze video zie jij mijn eerste indruk van het apparaat, een interview met de oprichters Toon Overbeeke en Bria
Vitestro’s Aletta system is redefining clinical workflows as the world’s first Autonomous Robotic Phlebotomy Device (ARPD). Using near‑infrared imaging and Dopp
Jaarlijks worden in Nederland tientallen miljoenen bloedafnames gedaan. Een handeling die steeds vaker onder druk staat door personeelstekorten in de zorg. Het
With a 94.3% success rate, this AI-powered tech by Beijing Magicnurse is redefining the future of healthcare. 🚀🩺 Would you let a robot draw your blood? #heal
En los Países Bajos, la startup Vitestro ha desarrollado un dispositivo robótico autónomo que podría cambiar la forma en que se realizan las extracciones de san
Aletta is a robot that finds veins, inserts the needle, and draws blood automatically. 95% first-stick success — and it can handle the full process on its own.
Otonom Kan Alma Robotu Aletta Geleneksel kan alma yöntemlerindeki değişkenliği ve hata payını minimize etmek için tasarlanan Aletta, çok modlu görüntüleme siste
Reality vs attention
Vitestro draws attention at the 36th percentile but verifies reality at the 11th percentile among service robots. Hype Gap +24.8, 16th widest among service robots.
6-month trend
Analysis
Safety profile within acceptable range for category. Active fundraising activity with a recent closing. Deployment footprint remains limited relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 29, 2026